565 related articles for article (PubMed ID: 2960790)
1. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
Coveney JR; Robbins MS
J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
[TBL] [Abstract][Full Text] [Related]
2. Effects of altered physiologic states on clearance and biodistribution of technetium-99m MAG3, iodine-131 OIH, and iodine-125 iothalamate.
Taylor A; Eshima D
J Nucl Med; 1988 May; 29(5):669-75. PubMed ID: 2967354
[TBL] [Abstract][Full Text] [Related]
3. Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers.
Taylor A; Eshima D; Fritzberg AR; Christian PE; Kasina S
J Nucl Med; 1986 Jun; 27(6):795-803. PubMed ID: 2940350
[TBL] [Abstract][Full Text] [Related]
4. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.
Taylor A; Ziffer JA; Steves A; Eshima D; Delaney VB; Welchel JD
Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734
[TBL] [Abstract][Full Text] [Related]
5. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
Kabasakal L; Turoğlu HT; Onsel C; Ozker K; Uslu I; Atay S; Cansiz T; Sönmezoğlu K; Altiok E; Isitman AT
J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m labeled renal function and imaging agents: III. Synthesis of 99mTc-MAG3 and biodistribution of by-products.
Brandau W; Bubeck B; Eisenhut M; Taylor DM
Int J Rad Appl Instrum A; 1988; 39(2):121-9. PubMed ID: 2833469
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m-N,N-ethylenedicysteine--a comparative study of renal scintigraphy with technetium-99m-MAG3 and iodine-131-OIH in patients with obstructive renal disease.
Ozker K; Onsel C; Kabasakal L; Sayman HB; Uslu I; Bozluolçay S; Cansiz T; Kapicioğlu T; Urgancioğlu I
J Nucl Med; 1994 May; 35(5):840-5. PubMed ID: 8176468
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m labeled renal function and imaging agents: II. Clinical evaluation of 99mTc MAG3 (99mTc mercaptoacetylglycylglycylglycine).
Bubeck B; Brandau W; Steinbächer M; Reinbold F; Dreikorn K; Eisenhut M; Georgi P
Int J Rad Appl Instrum B; 1988; 15(1):109-18. PubMed ID: 2965116
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement.
Fritzberg AR; Kasina S; Eshima D; Johnson DL
J Nucl Med; 1986 Jan; 27(1):111-6. PubMed ID: 2934521
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m (99mTc) mercaptoacetyltriglycine: update on the new 99mTc renal tubular function agent.
Eshima D; Taylor A
Semin Nucl Med; 1992 Apr; 22(2):61-73. PubMed ID: 1534184
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of technetium-99m-L,L-EC in renal transplant recipients: a comparative study with technetium-99m-MAG3 and iodine-125-OIH.
Stoffel M; Jamar F; Van Nerom C; Verbruggen A; Mourad M; Leners N; Squifflet JP; Beckers C
J Nucl Med; 1994 Dec; 35(12):1951-8. PubMed ID: 7989976
[TBL] [Abstract][Full Text] [Related]
12. [99mTc-MAG3 and 131I-OIH in patients with kidney insufficiency and with normal kidneys].
Keske U; Cordes M; Wilfling M; Hunger J; Hosten N; Gahl G
Rofo; 1990 Mar; 152(3):287-92. PubMed ID: 2157251
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 99mTc-mercaptoacetyltriglycine and [131I]-o-iodohippurate elimination in perfused rat kidney.
Trejtnar F; Laznicek M; Laznickova A
Nucl Med Biol; 2003 Jan; 30(1):45-9. PubMed ID: 12493542
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Tc-99m mercaptoacetyltriglycine in patients with impaired renal function.
Taylor A; Eshima D; Christian PE; Milton W
Radiology; 1987 Feb; 162(2):365-70. PubMed ID: 2948212
[TBL] [Abstract][Full Text] [Related]
15. Renal and extrarenal clearance of 99mTc-MAG3: a comparison with 125I-OIH and 51Cr-EDTA in patients representing all levels of glomerular filtration rate.
Rehling M; Nielsen BV; Pedersen EB; Nielsen LE; Hansen HE; Bacher T
Eur J Nucl Med; 1995 Dec; 22(12):1379-84. PubMed ID: 8586082
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders.
Jafri RA; Britton KE; Nimmon CC; Solanki K; Al-Nahhas A; Bomanji J; Fettich J; Hawkins LA
J Nucl Med; 1988 Feb; 29(2):147-58. PubMed ID: 2964516
[TBL] [Abstract][Full Text] [Related]
17. Technetium-99m MAG-3 clearances after captopril in experimental renovascular hypertension.
Lee HB; Blaufox MD
J Nucl Med; 1989 May; 30(5):666-71. PubMed ID: 2523959
[TBL] [Abstract][Full Text] [Related]
18. 99mTc-MAG3 kinetics in the normal pig. A comparison to 131I-OIH and 125I-iothalamate after single injection and during continuous infusion.
Rehling M; Frøkiaer J; Poulsen EU; Marqversen J; Nielsen BV; Bacher T
Clin Physiol; 1995 Jan; 15(1):57-71. PubMed ID: 7712693
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of renal scintigraphy and clearance with technetium-99m-MAG3 and iodine-123-hippurate in patients with renal disorders.
Müller-Suur R; Bois-Svensson I; Mesko L
J Nucl Med; 1990 Nov; 31(11):1811-7. PubMed ID: 2146371
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of technetium-99m-MAG3 in humans.
Bubeck B; Brandau W; Weber E; Kälble T; Parekh N; Georgi P
J Nucl Med; 1990 Aug; 31(8):1285-93. PubMed ID: 2143528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]